Could stem cells tame brain inflammation? new study tracks Real-World results

NCT ID NCT07145502

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 76 people with autoimmune or post-infection brain inflammation who are receiving stem cell or exosome treatments. Researchers will track changes in symptoms, inflammation markers, and quality of life. The goal is to see if these experimental therapies can help when standard treatments have failed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

stem cells and exosomes

What this could lead to

If successful, this could point toward a new way to manage hard-to-treat brain inflammation conditions like autoimmune encephalitis.

What could go wrong

This is an early observational study with no control group, so results may not prove the treatment works. Risks include reactions to the infusions and uncertainty about long-term benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE ENCEPHALITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune disorder of the nervous system autoimmune encephalitis demyelinating disease of central nervous system

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Biocells Medical

    Warsaw, 01-234, Poland